You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: July 15, 2024

CLINICAL TRIALS PROFILE FOR MECAMYLAMINE HYDROCHLORIDE


✉ Email this page to a colleague

« Back to Dashboard


All Clinical Trials for Mecamylamine Hydrochloride

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00006399 ↗ Effects of Estrogen on Memory in Post-Menopausal Women and Patients With Alzheimer's Disease Completed Alzheimer's Association Phase 2 1999-09-01 The goal of this study is to examine whether the administration of estrogen to post-menopausal women and women with mild to moderate Alzheimer's disease will enhance their memory and their capacity for learning.
NCT00006399 ↗ Effects of Estrogen on Memory in Post-Menopausal Women and Patients With Alzheimer's Disease Completed Eisai Inc. Phase 2 1999-09-01 The goal of this study is to examine whether the administration of estrogen to post-menopausal women and women with mild to moderate Alzheimer's disease will enhance their memory and their capacity for learning.
NCT00006399 ↗ Effects of Estrogen on Memory in Post-Menopausal Women and Patients With Alzheimer's Disease Completed Pfizer Phase 2 1999-09-01 The goal of this study is to examine whether the administration of estrogen to post-menopausal women and women with mild to moderate Alzheimer's disease will enhance their memory and their capacity for learning.
NCT00006399 ↗ Effects of Estrogen on Memory in Post-Menopausal Women and Patients With Alzheimer's Disease Completed National Center for Research Resources (NCRR) Phase 2 1999-09-01 The goal of this study is to examine whether the administration of estrogen to post-menopausal women and women with mild to moderate Alzheimer's disease will enhance their memory and their capacity for learning.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Mecamylamine Hydrochloride

Condition Name

Condition Name for Mecamylamine Hydrochloride
Intervention Trials
Major Depressive Disorder 9
Depression 6
Smoking 2
Subjective Cognitive Decline 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for Mecamylamine Hydrochloride
Intervention Trials
Depressive Disorder 11
Depressive Disorder, Major 10
Depression 10
Disease 9
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for Mecamylamine Hydrochloride

Trials by Country

Trials by Country for Mecamylamine Hydrochloride
Location Trials
United States 117
India 42
Japan 11
Colombia 4
Germany 4
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for Mecamylamine Hydrochloride
Location Trials
Ohio 7
Florida 6
Connecticut 6
California 6
Kansas 6
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for Mecamylamine Hydrochloride

Clinical Trial Phase

Clinical Trial Phase for Mecamylamine Hydrochloride
Clinical Trial Phase Trials
Phase 4 1
Phase 3 7
Phase 2 10
[disabled in preview] 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for Mecamylamine Hydrochloride
Clinical Trial Phase Trials
Completed 24
Not yet recruiting 2
Terminated 2
[disabled in preview] 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Mecamylamine Hydrochloride

Sponsor Name

Sponsor Name for Mecamylamine Hydrochloride
Sponsor Trials
AstraZeneca 10
Targacept Inc. 7
Yale University 3
[disabled in preview] 3
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for Mecamylamine Hydrochloride
Sponsor Trials
Industry 23
Other 22
U.S. Fed 4
[disabled in preview] 4
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.